Rhinitis, Allergic, Perennial News

Concordia International Corp. (NASDAQ:CXRX) Experiences Light ... - HugoPress



Concordia International Corp. (NASDAQ:CXRX) Experiences Light ... 
HugoPress
Trading was light with 14K shares changing hands on Friday. Shares saw a steep decrease in trading volume of 94.75% under the normal average daily ...

and more » 


Allergic Rhinitis Drugs Market Industry Segments, Drivers, and ... - Medgadget (blog)



Allergic Rhinitis Drugs Market Industry Segments, Drivers, and ... 
Medgadget (blog)
The report on global Allergic Rhinitis Drugs market evaluates the growth trends of the industry through historical study and estimates future prospects bas.

and more » 


Concordia International Corp. (CXRX) Hits a New 52-Week Low - First News 24



KL Daily
 
Concordia International Corp. (CXRX) Hits a New 52-Week Low 
First News 24
... for the treatment of attention-deficit hyperactivity disorder, head lice infestation, and pulmonary diseases such as asthma; and control of severe or incapacitating allergic conditions such as atopic dermatitis, and seasonal and perennial allergic ...
Concordia International Corp. - CXRX - Stock Price Today - Zacks Zacks Investment Research

all 45 news articles » 


Research report explores the allergy immunotherapy market analysis - WhaTech



Research report explores the allergy immunotherapy market analysis 
WhaTech
This report provides a detailed analysis of the Allergy Immunotherapy market with a description of market sizing and growth, segmentation of market by products & services and major markets, top market players etc. The report recapitulates the factors ...

and more » 


Hay Fever Market Detailed Analysis and Forecast by 2025 - LANews By Abhishek Budholiya (press release) (blog)



LANews By Abhishek Budholiya (press release) (blog)
 
Hay Fever Market Detailed Analysis and Forecast by 2025 
LANews By Abhishek Budholiya (press release) (blog)
Seasonal allergic rhinitis is caused by the hypersensitivity and allergic reaction to the airborne substances such as pollen from grass & weeds and mold spores. Perennial allergic rhinitis is caused by inhalation of dander, pet hair, and dust mites ...

 


Pharmed LLC having great success on Amazon.com - PR Web (press release)



Pharmed LLC having great success on Amazon.com 
PR Web (press release)
Nasal SpaŽ can be used daily to gently moisturize and clear the nasal passage, relieving dry and stuff noses associated with hay fever, cold, seasonal and perennial allergic rhinitis, sinusitis and rhynopharyngitis. ?It's safe for use by all family ...

 


Concordia International Corp. (NASDAQ:CXRX) Experiences Lighter than Usual Trading Volume - First News 24



Concordia International Corp. (NASDAQ:CXRX) Experiences Lighter than Usual Trading Volume 
First News 24
... for the treatment of attention-deficit hyperactivity disorder, head lice infestation, and pulmonary diseases such as asthma; and control of severe or incapacitating allergic conditions such as atopic dermatitis, and seasonal and perennial allergic ...

and more » 


Explore Global allergy immunotherapy market forecast 2017-2021 ... - WhaTech



Explore Global allergy immunotherapy market forecast 2017-2021 ... 
WhaTech
The report titled ?Global Allergy Immunotherapy Market (2017-2021 Edition)?, provides an in-depth analysis of the global allergy immunotherapy market by value ...

and more » 


Concordia International Corp. (NASDAQ:CXRX) Takes Off in Trading Today ? Up by 9.32% - First News 24



Concordia International Corp. (NASDAQ:CXRX) Takes Off in Trading Today ? Up by 9.32% 
First News 24
... for the treatment of attention-deficit hyperactivity disorder, head lice infestation, and pulmonary diseases such as asthma; and control of severe or incapacitating allergic conditions such as atopic dermatitis, and seasonal and perennial allergic ...

and more » 


Concordia International Corp. (NASDAQ:CXRX) Sees Significantly Lower Trading Volume - First News 24



Concordia International Corp. (NASDAQ:CXRX) Sees Significantly Lower Trading Volume 
First News 24
... control of severe or incapacitating allergic conditions such as atopic dermatitis, and seasonal and perennial allergic rhinitis. The company was formerly known as Concordia Healthcare Corp. and changed its name to Concordia International Corp. in 2016.

and more »